Drug profile · INN
estrogens, conjugated
PMB 200
estrogens, conjugated (PMB 200) is a estrogen receptor agonist. Route of administration: oral-28. Current US regulatory status: approved.
Drug details — estrogens, conjugated
- US status
- approved
- Class
- —
- Route
- ORAL-28
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
estrogens, conjugated (PMB 200) is a estrogen receptor agonist. Route of administration: oral-28. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is estrogens, conjugated?
estrogens, conjugated (PMB 200) is a estrogen receptor agonist. Route of administration: oral-28. Current US regulatory status: approved.
What is the brand name for estrogens, conjugated?
PMB 200 is a marketed brand name for estrogens, conjugated. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of estrogens, conjugated?
estrogens, conjugated has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.